Skip to content
value.today

AbbVie Inc. vs ProPhase Labs, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • AbbVie Inc. is the larger company by market value: $514.0 B against $87 M for ProPhase Labs, Inc., 5908 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for ProPhase Labs, Inc.). ProPhase Labs, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • AbbVie Inc. had more revenue: $61.2 B against $4 M for ProPhase Labs, Inc., both in the year to December 2025.
  • AbbVie Inc. made a net profit of $4.2 B, while ProPhase Labs, Inc. made a net loss of $15 M.
  • AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -339.6% for ProPhase Labs, Inc.
  • AbbVie Inc. employs more people: 57,000 against 19 at ProPhase Labs, Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $228,421 at ProPhase Labs, Inc.
  • AbbVie Inc.'s revenue grew faster in its latest fiscal year: +8.6% against -35.9% for ProPhase Labs, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01773555327092020202120222023202420252026AbbVie Inc. 390ProPhase Labs, Inc. 395

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$15B$31B$46B$61B201720182019202020212022202320242025AbbVie Inc. $61BProPhase Labs, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbVie Inc.
ABBV · #26 in the world
ProPhase Labs, Inc.
PRPH
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded20131989
Size
Market cap$514.0 B$87 M*
Revenue$61.2 B$4 M
Net income$4.2 B▲ best$-15 M
Employees57,00019
Valuation
P/E ratio49.7×—
Price to sales7.8×—
Free cash flow yield3.5%—
Profitability
Gross margin70.2%▲ best31.8%
Operating margin24.6%▲ best-415.9%
Net margin6.9%▲ best-339.6%
Return on equity—-271.4%
Return on invested capital16.0%—
Growth
Revenue growth8.6%▲ best-35.9%
Revenue growth, 3 years a year1.8%▲ best-67.2%
Earnings per share growth-1.3%—
Financial strength
Interest cover5.2×▲ best-2.6×
Cash
Free cash flow margin29.1%▲ best-192.2%
Shareholder returns
Dividend yield2.3%—
Shareholder yield2.5%—
Strength scores
Piotroski F-score8 of 9—
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jan 2024; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, AbbVie Inc. or ProPhase Labs, Inc.?

AbbVie Inc. is the larger company by market value: $514.0 B against $87 M for ProPhase Labs, Inc., 5908 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for ProPhase Labs, Inc.). ProPhase Labs, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, AbbVie Inc. or ProPhase Labs, Inc.?

AbbVie Inc. had more revenue: $61.2 B against $4 M for ProPhase Labs, Inc., both in the year to December 2025. AbbVie Inc. made a net profit of $4.2 B, while ProPhase Labs, Inc. made a net loss of $15 M.

Which is more profitable, AbbVie Inc. or ProPhase Labs, Inc.?

AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -339.6% for ProPhase Labs, Inc.

Which has more employees, AbbVie Inc. or ProPhase Labs, Inc.?

AbbVie Inc. employs more people: 57,000 against 19 at ProPhase Labs, Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $228,421 at ProPhase Labs, Inc.

Which is growing faster, AbbVie Inc. or ProPhase Labs, Inc.?

AbbVie Inc.'s revenue grew faster in its latest fiscal year: +8.6% against -35.9% for ProPhase Labs, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.